After more than 20 years on the Turkish market, Chr. Hansen has acquired the remaining 50% of its Turkish subsidiary Peyma Chr-Hansen.

According to the company,Turkey is a strategically important market seeing steady growth in cultures, enzymes and natural colours, and Chr. Hansen wishes to strengthen and expand its activities in the region.

“We have been present with the Peyma Chr-Hansen Joint Venture in Turkey since 1989,” said Jacob Vishof Paulsen, group vice president, Europe, Middle East and Africa, Chr. Hansen. “With this acquisition we can fully integrate operations into the rest of the Chr. Hansen organisation, sustaining the whole Group’s success in the future,”

The take-over is said to have taken place in full consensus with general manager and shareholder, Toni Ciprut.

“We wish to thank Mr Ciprut for his efforts and his success throughout the many years,” said Paulsen. “He has been instrumental in making Chr. Hansen a major player on the Turkish food ingredients market, and I am pleased to announce that he will continue to support the management team as a consultant over the coming two years.”

The role of new country manager of Chr. Hansen Turkey will be assumed by Carsten Rou, who has been with Chr. Hansen for 25 years, most recently as head of culture and enzyme sales in North America.